LDC (Managers) Limited has divested Synexus Clinical Research to Jaguar Holdings Company, a holdings company of Pharmaceutical product Development (PPD).
The $258.33m transaction generates 2.3x money multiple for LDC and enables Synexus to achieve a substantial growth in the market.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
JSS Medical Research plans to establish its presence and provide its services to clients in Europe and surrounding regions by acquiring Bonne Sante, a marketing company specialised in promotion of gastroenterology products.
The acquisition enables both companies to improve their operational efficiencies and international business development and expand their client services.